TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas
- 16 January 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (3), 359-365
- https://doi.org/10.1038/modpathol.2008.236
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiationOncogene, 2008
- A causal role for ERG in neoplastic transformation of prostate epitheliumProceedings of the National Academy of Sciences, 2008
- Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancerBritish Journal of Cancer, 2007
- Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissuesLaboratory Investigation, 2007
- Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate CancerClinical Cancer Research, 2007
- Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerLaboratory Investigation, 2007
- TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohortOncogene, 2007
- Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate CancerCancer Research, 2006
- TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate CancerCancer Research, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005